Top Markets
#1 Merlin's Seal BTC Merlin's Seal BTC +41.75%
#2 0G 0G +29.50%
#3 SAFEcoin SAFEcoin +27.44%
#4 Seeker Seeker +23.54%
#5 Pons Pons +21.03%
#6 Zora Zora +20.06%
#7 VVS Finance VVS Finance +18.18%
#8 Full Moon Full Moon +17.70%
#9 Axelar Axelar +17.50%
#10 Concordium Concordium +17.01%
Coin of the day
Merlin's Seal BTC Merlin's Seal BTC
Setări
Limbă
ROMâNă
Monedă
USD
Temă
TransThera Sciences (Nanjing). Inc. TransThera Sciences (Nanjing). Inc.

TransThera Sciences (Nanjing). Inc.

2617
Rang în acțiuni #13149
TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company,... TransThera Sciences (Nanjing), Inc., clinical stage biopharmaceutical company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases. The company provides Tinengotinib (TT-00420), a MTK inhibitor that is in clinical stage for the treatment of recurrent or refractory drug-resistant solid tumors. It also develops TT-00973, a kinase inhibitor for treating various cancers; TT-01488, a BTK inhibitor for the treatment of B-cell lymphoma; TT-01688, an oral S1P1 modulator for treating various inflammatory diseases; TT-00920, an oral PDE9 inhibitor used for treating central nervous system diseases; TT-01025, an oral irreversible VAP-1 inhibitor designed for the treatment of NASH; and TT-02332, a NLRP3 inhibitor for metabolic and inflammatory diseases. The company has a collaboration with Neurocrine Biosciences, Inc. to develop NLRP3 inhibitors for multiple disease. TransThera Sciences (Nanjing), Inc. was formerly known as Nanjing TransThera Biosciences Co. Ltd. and changed its name to TransThera Sciences (Nanjing), Inc. in July 2021. The company was incorporated in 2014 and is headquartered in Nanjing, China.
Preț acțiune
$1.30
Capitalizare de piață
$516.38M
Schimbare (1 zi)
-2.21%
Schimbare (1 an)
-81.27%
Țară
CN
Tranzacționează TransThera Sciences (Nanjing). Inc. (2617)

Categorie

Healthcare
Istoric dividende pentru TransThera Sciences (Nanjing). Inc. (2617)
TransThera Sciences (Nanjing). Inc. (simbol acțiune: 2617) a efectuat un total de 0 plăți de dividende.
Suma tuturor dividendelor (ajustată pentru split-uri de acțiuni) este: 0.00
Randamentul dividendului (TTM): 0
Plăți de dividende pentru TransThera Sciences (Nanjing). Inc. (2617) din 2026 până în 2026
Plăți anuale de dividende
An Dividend (ajustat pentru split de acțiuni) Schimbă
Nu sunt suficiente date pentru perioada selectată.
Lista tuturor plăților de dividende
An Dividend Schimbă
Nu sunt suficiente date pentru perioada selectată.
Dividende ale companiilor similare sau concurente
Companie Număr de plăți de dividende Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH